Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Clinical Trial with CAR-37 T Cells for the Treatment of Patients with Relapsed or Refractory CD37+ Hematologic Malignancies

NCT04136275 is registered in ClinicalTrials.gov with Marcela V. Maus, M.D.,Ph.D. as lead sponsor.

NCT NCT04136275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04136275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Clinical Trial with CAR-37 T Cells for the Treatment of Patients with Relapsed or Refractory CD37+ Hematologic Malignancies
Lead sponsor
Marcela V. Maus, M.D.,Ph.D.
Phase
Phase 1
Overall status
Completed
Start date
June 19, 2020
Completion date
March 1, 2024
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancy, leukemia, lymphoma, lymphoma, b-cell, lymphoma, non-hodgkin, lymphoma, t-cell